Shanikant Singh, Rachna khatri, Bhawani Shankar Verma


Background: Dengue or dengue fever is one of the most important mosquito-borne viral disease in worldwide distribution. The virus is the member of flavivirus group which typically is a single stranded RNA virus.

Methods: This study was conducted onSeptember 2019 to December 2019 and specimens which were received blood samples in the Microbiology lab for detection of dengue Through card method, we used the DAY1 kit by J Mitra and DENGUE DUO by SD company which is detected dengue NS1, IgM and IgG antibodies, from patients with clinical suspicion of dengue fever-like illness, who presented to the outpatient's department and indoor patients were admitted NIMS hospital Jaipur, Rajasthan. 

Results: Among 1222 patients is dengue suspected and diagnosed as 390dengue positive patients. Which is dengue Ns1 383 (95.2%), IgM 18 (4.3%) and IgG 2 (0.5%). And according to male and female as well as 294 (75.4%) & 96 (24.6%). Then age group wise more predominant 11-20 years 30.8%. Most predominant thrombocytopenia is according to platelet count less than 50000 / microliter (25.6%) were patients. Among leukocytopenia is 48.7% is dengue fever patients.

Conclusions: Present study concludes that clinical surveillance about dengue haemorrhagic fever is important as timely recognition can influence outcome and may prevent any compilations.


Dengue, Thrombocytopenia, Leukocytopenia.

Full Text:



WHO: Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever, 2011:11-16.

Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008;371 (9611):500–509.

Baruah J, Ananda S, Kumar AG. Incidence of dengue in a tertiary care centreKasturba Hospital, 2006; 49(3):462-3.

Abrol A, Dewan A, Agarwal N, Galhotra A, Goel NK, et al. A clinic-epidemiological profile of dengue fever cases in a peri-urban area of Chandigarh, 2007; 5 (7).

Martina BE, Koraka P, Osterhaus AD: Dengue virus pathogenesis: an integrated view. Clinical microbiology reviews 2009, 22(4): 564-581.

Harris E, Videa E, Perez L, Sandoval E, Tellez Y, Perez ML, Cuadra R, Rocha J, Idiaquez W, Alonso RE et al: Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua: 2000, 63(1-2): 5-11.

.WHO: Dengue haemorrhagic fever diagnosis, treatment and control. WHO: Geneva 1997, 2nd edn.

De Castro RA dCJ, Barez MY, Frias MV, Dixit J, Genereux M.: Thrombocytopenia associated with dengue haemorrhagic fever responds to intravenous administration of anti-D (Rh (o) -D) immune globulin, 2007, 76(4):737-742.

Khan DM KK, S S, V R M: Evaluation of thrombocytopenia in dengue infection along with seasonal variation in rural melmaruvathur. Journal of clinical and diagnostic research: 2014, 8(1):39-42.

Vijaykumar TS, Chandy S, Satish N, Abraham M, Abraham P, et al. Is dengue an emerging as a major public health problem, 2005;121:100-07.

Sri Chaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best pract, 2000; 13: 261-276.

.RNMakroo, Raina V, Kumar P, Kanth R K.Role of Platelet Transfusion in the managmenet of dengue patients in a tertiary care hospital, 2007; 1:4-73.

Chouhan GS, Rodrigues FM, Sheikh BH, Ilkal MA, Khangaro SS, et al. Clinical and virological study of dengue fever outbreak in Jalore city, Rajasthan, 1985; 91: 414

Prathyusha CV, Srinivasa Rao M, Sudarsini P, Uma Maheswara Rao K. Clinico‑haematological profile and outcome of dengue fever in children. Int J Curr Microbiol Appl Sci 2013;2:338‑46 .

Ukey PM, Bondade SA, Paunipagar PV, Powar RM, Akulwar SL. Study of Sero- prevalence of Dengue Fever in Central India. Ind J Community Med. 2010; 35(4): 517-19.

M, Chatterjee T, Choudhary G.S., Srinivas. V, Kataria V.K. Dengue: A clinic haematological profile. MJAFI, 2008; 64: 333-336.

Kumar S, Lakhiwal R, Aswal V, Gajraj S, Patel I, Chakranarayan A, Garg S. A study of dengue and hepatopathy. 2017;5(6):2625-8.


  • There are currently no refbacks.